Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Salim Hayek
  • Christoph Roderburg
  • Pennelope Blakely
  • Christopher Launius
  • Jesper Eugen-Olsen
  • Frank Tacke
  • Sofia Ktena
  • Verena Keitel
  • Mark Luedde
  • Evangelos J Giamarellos-Bourboulis
  • Tom Luedde
  • Sven H Loosen
  • Izzet Altintas (Member of study group)
View graph of relations

BACKGROUND: Severe coronavirus disease 2019 (COVID-19) is the result of a hyper-inflammatory reaction to the severe acute respiratory syndrome coronavirus 2. The biomarkers of inflammation have been used to risk-stratify patients with COVID-19. Osteopontin (OPN) is an integrin-binding glyco-phosphoprotein involved in the modulation of leukocyte activation; its levels are associated with worse outcomes in patients with sepsis. Whether OPN levels predict outcomes in COVID-19 is unknown.

METHODS: We measured OPN levels in serum of 341 hospitalized COVID-19 patients collected within 48 h from admission. We characterized the determinants of OPN levels and examined their association with in-hospital outcomes; notably death, need for mechanical ventilation, and need for renal replacement therapy (RRT) and as a composite outcome. The risk discrimination ability of OPN was compared with other inflammatory biomarkers.

RESULTS: Patients with COVID-19 (mean age 60, 61.9% male, 27.0% blacks) had significantly higher levels of serum OPN compared to healthy volunteers (96.63 vs. 16.56 ng/mL, p < 0.001). Overall, 104 patients required mechanical ventilation, 35 needed dialysis, and 53 died during their hospitalization. In multivariable analyses, OPN levels ≥140.66 ng/mL (third tertile) were associated with a 3.5 × (95%CI 1.44-8.27) increase in the odds of death, and 4.9 × (95%CI 2.48-9.80) increase in the odds of requiring mechanical ventilation. There was no association between OPN and need for RRT. Finally, OPN levels in the upper tertile turned out as an independent prognostic factor of event-free survival with respect to the composite endpoint.

CONCLUSION: Higher OPN levels are associated with increased odds of death and mechanical ventilation in patients with COVID-19, however, their utility in triage is questionable.

Original languageEnglish
Article number3907
JournalJournal of Clinical Medicine
Issue number17
Pages (from-to)1-13
Number of pages13
Publication statusPublished - 30 Aug 2021

    Research areas

  • CRP, Coronavirus disease 2019, Death, Mechanical ventilation, OPN, Outcomes, PCT, Procalcitonin, Renal replacement therapy, Risk prediction, SARS-CoV-2

ID: 67409028